Growth Metrics

Idexx Laboratories (IDXX) Short term Debt (2016 - 2025)

Idexx Laboratories has reported Short term Debt over the past 17 years, most recently at $75.0 million for Q4 2025.

  • Quarterly results put Short term Debt at $75.0 million for Q4 2025, down 55.3% from a year ago — trailing twelve months through Dec 2025 was $75.0 million (down 55.3% YoY), and the annual figure for FY2025 was $75.0 million, down 55.3%.
  • Short term Debt for Q4 2025 was $75.0 million at Idexx Laboratories, down from $150.0 million in the prior quarter.
  • Over the last five years, Short term Debt for IDXX hit a ceiling of $633.0 million in Q3 2022 and a floor of $73.5 million in Q4 2021.
  • Median Short term Debt over the past 5 years was $158.9 million (2024), compared with a mean of $207.9 million.
  • Biggest five-year swings in Short term Debt: tumbled 74.33% in 2021 and later surged 744.11% in 2022.
  • Idexx Laboratories' Short term Debt stood at $73.5 million in 2021, then soared by 240.14% to $250.0 million in 2022, then plummeted by 70.0% to $75.0 million in 2023, then skyrocketed by 123.72% to $167.8 million in 2024, then crashed by 55.3% to $75.0 million in 2025.
  • The last three reported values for Short term Debt were $75.0 million (Q4 2025), $150.0 million (Q3 2025), and $579.0 million (Q2 2025) per Business Quant data.